Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril
- 28 February 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 25 (2) , 362-369
- https://doi.org/10.1016/0735-1097(94)00368-z
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Restenosis revisited: Insights provided by quantitative coronary angiographyAmerican Heart Journal, 1993
- Pharmacologic prevention of restenosis after coronary angioplastyCoronary Artery Disease, 1993
- Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty — A report from the M-HEART GrouptThe American Journal of Cardiology, 1990
- Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectorisThe American Journal of Cardiology, 1989
- Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1989
- Percutaneous Transluminal Coronary Angioplasty in 1985–1986 and 1977–1981New England Journal of Medicine, 1988
- Restenosis after arterial angioplasty: A hemorrheologic response to injuryThe American Journal of Cardiology, 1987
- Influence of intimal dissection on restenosis after successful coronary angioplasty.Circulation, 1985
- Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.Circulation, 1985
- Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry.Circulation, 1983